March 17, 2025 12:16 PM EDTUpdated 12:46 PM
Pharma
FDA+

All se­lect­ed drug­mak­ers agree to sec­ond round of price ne­go­ti­a­tions un­der the IRA

Nicole DeFeudis

Editor

The sec­ond round of Medicare price ne­go­ti­a­tions is now un­der­way for all 15 se­lect­ed drugs with signed agree­ments in place from the man­u­fac­tur­ers of those …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump’s HHS de­fends Biden-era stance on 340B re­bate mod­els

FDA staff re­turn to White Oak cam­pus en masse af­ter Trump ad­min­is­tra­tion push

In­cyte's stock sinks as piv­otal skin dis­ease da­ta dis­ap­point

As­traZeneca taps Al­teogen in deal worth more than $1.3B to make sub­cu­ta­neous can­cer drugs

Post-Hoc: Kennedy's an­ti-vac­cine ac­tions should­n't sur­prise any­one

George Church spin­out de­vel­op­ing ge­nom­i­cal­ly re­cod­ed or­gan­isms cuts most em­ploy­ees

A service from the Financial Times